Mark Gasparini, DPM
Podiatrist · Massapequa, NYNPI 1013000405
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,456 of the $5,910 with a category attached, or 75.4%. 38 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 26.0% of the total. Reporting peaked in 2024 at $2,132 and has fallen 70.2% since, to $636 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Organogenesis Inc.$736
- Smith+Nephew$626
- Medtronic$386
- Abbott$329
- Misonix Inc$182
- plus $2K from 32 others
What the payments were for
- Speaking & faculty fees$1693%
- Travel & lodging$1,28522%
- Food & beverage$4,45675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 8 | $1,535 |
| Organogenesis Inc. | 27 | $736 |
| Smith+Nephew | 19 | $626 |
| Medtronic(2 entities) | 3 | $386 |
| Abbott | 3 | $329 |
| Misonix Inc | 2 | $182 |
| Mimedx Group, Inc. | 3 | $179 |
| Medline Industries LP | 1 | $161 |
| Paratek Pharmaceuticals, Inc. | 6 | $149 |
| Biocomposites Inc | 1 | $136 |
| Osteomed LLC | 1 | $125 |
| KCI USA, Inc. | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Averitas Pharma Inc. | 1 | $122 |
| Tactile Systems Technology Inc | 3 | $121 |
| Hydrofera LLC | 1 | $119 |
| Convatec Inc. | 2 | $94 |
| AbbVie | 4 | $90 |
| Johnson & Johnson | 3 | $55 |
| Integra Lifesciences Corporation | 4 | $55 |
| Lilly USA, LLC | 3 | $49 |
| AstraZeneca | 2 | $38 |
| Aroa Biosurgery Incorporated | 2 | $35 |
| Novo Nordisk | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 2 | $33 |
| TEI Medical Inc. | 2 | $30 |
| Solventum Corporation | 1 | $29 |
| GSK | 1 | $27 |
| Zimmer Biomet | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $24 |
| Bioventus LLC | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Orthofix Medical, Inc. | 2 | $22 |
| DJO, LLC | 1 | $19 |
| Pfizer | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,453
- Apligraf$272
- Supera peripheral stent system$174
- TheraSkin$158
- ClosureFast$156
- Axium INS DRG IPG$151
- HawkOne$140
- Stimulan$136
- GRAFIX PL$132
- ACTIVAC$125
- SNAP$125
- Bio-Osteovation Allograft$125
- BIO-Osteovation (EXT)$125
- NUZYRA$125
- Kimyrsa$125
- PuraPly$124
- Qutenza$122
- HYDROFERA BLUE$119
- COLLAGENASE SANTYL$118
How this compares
$5,910 in reported general payments places this provider in the 90th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 43 | $1,087 |
| Doxycycline Hyclate | 27 | $512 |
| Clotrimazole | 11 | $427 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $331 |
| Mupirocin | 39 | $273 |
| Doxycycline Monohydrate | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Massapequa
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
- Ammar Al RubaiayNew Hyde Park$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.